Notes on Lymphocytes and Migration

Lymphocytes: Types, Roles, and Key Concepts

• Lymphocytes circulate as the primary adaptive immune cells. Two main flavors are:
  • T cells
  • B cells
• Natural killer (NK) cells are a third type discussed later; not the focus of this segment.
• Spleen as a secondary lymphoid tissue:
  • Secondary lymphoid tissues (e.g., spleen, lymph nodes) are involved in filtering antigens and mounting adaptive responses.
  • Primary lymphoid tissues are the sites where lymphocytes develop and mature: bone marrow (B cells) and thymus (T cells).
  • The spleen is not attached to lymphatic ducts like lymph nodes, and it filters the blood rather than the lymph. Hence, it handles blood-borne pathogens rather than exclusively lymph-borne antigens.
  • Lymph nodes receive lymph from lymphatic vessels; spleen receives blood-borne antigens.
• Lymphocyte surveillance and circulation:
  • Lymphocytes patrol the body (surveillance) for cognate antigens (the specific antigens they’re made to identify).
  • If they encounter their cognate antigen, they activate and proliferate to mount a targeted response.
  • If they do not encounter antigen, they continue circulating.
  • The question of tracking where an antigen entered: a key topic to be addressed later in the lecture series.

Antigen presentation and the role of APCs

• Antigen-presenting cells (APCs) such as macrophages and dendritic cells are responsible for detecting microbes in inflamed tissue and presenting antigenic fragments to T and B cells.
• APCs perform antigen processing:
  • They phagocytose microbes and degrade them into peptide fragments.
  • They present these fragments on MHC molecules to T cells (and B cells under certain contexts).
• Difference in recognition:
  • B cells recognize intact antigen on the surface of pathogens or particles.
  • T cells recognize peptide fragments that APCs present via MHC molecules.
• Activation and clonal expansion:
  • Upon recognition of their specific antigen, the APC activates the lymphocyte.
  • Activated lymphocytes undergo proliferation (clonal expansion) to mass-produce cells specific for that microbe.
• The importance of “cognate antigen”:
  • Cognate antigen is the specific antigen a lymphocyte is made to identify.

Induction phase vs. Effector phase in lymphocyte responses

• Induction phase (homing to testing grounds):
  • Naive lymphocytes travel to secondary lymphoid tissues (e.g., lymph nodes, spleen) where antigen is deposited and tested.
  • This phase is about visiting multiple sites to find the antigen and become activated.
• Effector phase (meeting the actual infection):
  • Once activated, mature lymphocytes become effector cells and migrate to the site of infection.
  • They target the inflamed tissue where the pathogen is actively present.
  • For a localized infection (e.g., a cut on the knee), the response should concentrate at that site rather than everywhere.
• Two mechanisms to target inflamed tissue (homing):
  • Homing receptors on lymphocytes are matched with vascular addressins on endothelial cells.
  • Endothelial cells in inflamed tissue express addressins; lymphocytes display corresponding receptors to exit circulation at those sites.
• Endothelial cells and addressing sites:
  • Vascular addressins are expressed by endothelial cells lining blood vessels in tissues.
  • These addresses (addresses in the endothelium) help lymphocytes know where to exit circulation.
  • The large endothelial surface in high-endothelial venules (HEVs) provides many opportunities for lymphocytes to interact with addressins.
• The HEV (high endothelial venule):
  • A specialized vessel that enables lymphocytes (T and B cells) to exit the bloodstream into lymphoid tissue.
  • After testing, lymphocytes re-enter circulation and can travel to other lymph nodes, repeatedly surveilling for antigen.
• The two exit strategies from blood vessels:
  • Diapedesis: the primary route where lymphocytes squeeze between adjacent endothelial cells to exit the vessel.
  • Transcellular migration: a less common route where lymphocytes migrate through an endothelial cell itself.
• Commonality of diapedesis:
  • Most lymphocytes exit via diapedesis between endothelial cells (trans-endothelial migration).
• The concept of vascular addresses and homing receptors:
  • Lymphocytes express homing receptors that determine where they can exit the bloodstream.
  • Endothelial cells at those sites present vascular addressins that bind the matching receptors on lymphocytes.
  • The expression pattern of receptors changes as lymphocytes mature and become activated, altering their migration destinations.
• Developmental changes in homing receptors (the fairy tale analogy):
  • Naive lymphocytes primarily express certain homing receptors that guide them to classic lymphoid tissues (e.g., L-selectin; GlyCAM-1 interactions with HEVs).
  • Upon activation and maturation, lymphocytes upregulate a different set of receptors (e.g., VLA-4) enabling exit at inflammatory sites through VCAM-1 addresses, reflecting a shift from surveillance to active defense.
• Practical takeaway: different stages of lymphocyte development determine where they exit from circulation and where they go to perform their function.

Naive, activated/mature, and memory lymphocytes; consequences for trafficking

• Naive lymphocytes:
  • Express a specific set of homing receptors (e.g., L-selectin) and target vascular addresses such as HEVs in lymph nodes and spleen.
  • Their surveillance pattern is broad, testing multiple lymphoid tissues for antigen presence.
• Activated/mature (effector) lymphocytes:
  • After encountering antigen and being activated, these cells change their homing receptor profile.
  • They gain the ability to exit at sites of inflammation via different vascular addresses (e.g., VLA-4 binding VCAM-1).
  • They specifically traffic to inflamed or infected tissues where their activity is needed.
• Memory lymphocytes:
  • After the pathogen is cleared, most effector cells die, but memory cells persist in circulation.
  • Memory cells retain a restricted set of homing receptors but are primed for rapid response upon re-exposure to the same antigen.
  • Memory cells continue surveillance but with a narrower, more targeted pattern, often aligned with prior infection sites (e.g., mucosal tissues).
• Mucosal immune system and tissue-specific surveillance:
  • Some memory lymphocytes are particularly equipped to populate mucosal tissues (GALT, BALT, and other MALT components).
  • If a memory cell was activated in a mucosal tissue, it tends to reside in or preferentially traffic to mucosal tissues again upon reactivation.
  • Common mucosal surveillance implies shared vascular addresses across mucosal tissues, enabling memory cells to patrol these sites efficiently.
• Pregnancy example and mucosal protection:
  • A memory lymphocyte from a gut mucosal infection may migrate to the mammary gland during pregnancy.
  • The advantage is that antibodies are secreted into colostrum (early breast milk), providing passive mucosal protection to the newborn.
• How B cells contribute to mucosal immunity:
  • Activated B cells can become plasma cells that secrete antibodies (Ig).
  • These antibody-secreting cells can home to mucosal tissues (gut, urogenital tract, respiratory tract) and other sites where the specific antigen was encountered.
  • The antibodies (Igs) produced by plasma cells provide targeted protection at mucosal surfaces.

The role of MALT, GALT, and mucosal memory in surveillance

• Mucosa-associated lymphoid tissue (MALT) includes:
  • Gut-associated lymphoid tissue (GALT)
  • Bronchial-associated lymphoid tissue (BALT)
  • Other mucosal tissues that line openings to the outside environment (eyes, mouth, nose, etc.)
• Lymphocytes activated by a mucosal antigen preferentially reside in mucosal tissues.
• Shared mucosal vascular addressing allows memory cells to surveil across mucosal sites more efficiently.
• Classic example of mucosal memory trafficking:
  • A memory lymphocyte activated by a gut pathogen can migrate to the stomach, mammary gland, and other mucosal tissues where similar vascular addresses exist.
• Mammary gland and lactational immunity:
  • Memory mucosal lymphocytes can migrate to the mammary gland during pregnancy and produce antibodies in milk to protect the newborn.

B cells, plasma cells, and antibody production

• B cells can differentiate into plasma cells that synthesize antibodies (immunoglobulins, Igs).
• Humoral response: antibodies produced by plasma cells neutralize pathogens, mark them for destruction, or block infection.
• B cells provide systemic and mucosal protection via antibodies that can travel to various mucosal surfaces following activation and clonal expansion.
• The concept of clonal expansion applies to both T and B lymphocytes: a single activated cell proliferates to generate a clone capable of recognizing the same antigen.

Quick recap of key terms and concepts

• Lymphocytes: T cells, B cells; NK cells as a related cytotoxic lymphocyte subset.
• Antigen-presenting cells (APCs): macrophages and dendritic cells that process antigens and present them via MHC to T cells (and indirectly help B cells).
• Cognate antigen: the specific antigen a lymphocyte is programmed to recognize.
• Naive vs activated (lymphoblasts) vs memory:
  • Naive: not yet exposed to antigen; broad surveillance.
  • Lymphoblast: actively proliferating precursor during activation.
  • Activated/effector: directed against a specific site; homing to infection.
  • Memory: long-lived, rapid responders upon re-exposure.
• Thymus vs bone marrow: sites of T cell and B cell development, respectively.
• HEV (high endothelial venule): specialized vessel enabling lymphocytes to exit blood into lymphoid tissue.
• Diapedesis: primary mechanism of leukocyte extravasation between endothelial cells.
• Transcellular migration: alternative route where the leukocyte traverses through an endothelial cell; less common.
• Homing receptors vs vascular addressins:
  • Homing receptors on lymphocytes determine where they can exit the bloodstream.
  • Addressins on endothelium define the tissue-specific exit points.
• Mucosal immunity (MALT, GALT, BALT): specialized surveillance and defense at mucosal surfaces; memory cells may preferentially reside here depending on where activation occurred.
• Plasma cells and antibodies: B cells differentiate into antibody-secreting cells that provide targeted immune protection.
• Granulocytes overview (brief reference):
  • Neutrophils: primarily antibacterial defense.
  • Eosinophils: defense against parasites.
  • Basophils: involved in allergic responses; mentioned as progenitors for APCs in the transcript.

Possible exam prompts and study cues

• Explain the difference between primary and secondary lymphoid tissues and why the spleen is categorized as a secondary lymphoid organ.
• Describe the role of HEVs in lymphocyte trafficking and how naive vs activated lymphocytes differ in their homing receptor profiles.
• Compare and contrast antigen recognition by B cells (intact antigen) and T cells (peptide fragments on MHC).
• Define induction and effector phases in the context of a localized infection and explain how lymphocytes know where to go.
• Outline how memory lymphocytes alter their trafficking patterns and why mucosal memory is especially important for protective immunity.
• Discuss how plasma cells derived from B cells contribute to mucosal and systemic immunity and the significance of antibody production in lactation.
• Describe diapedesis and transcellular migration and why diapedesis is the predominant mechanism for lymphocyte exit.
• Summarize the roles of B cells, T cells, and APCs in orchestrating the adaptive immune response and how these processes contribute to targeted pathogen elimination.